Table 1 Advantages, barriers and potential enablers of CPMs as endorsed by survey respondents; in weighted rank (r) order. Additionally, ‘% 1’ denotes the percentage of time an element was endorsed as the top-ranking
Advantages | r | % 1 |
|---|---|---|
Guides appropriate treatment | 299 | 53 |
Justifies treatment decisions made | 217 | 20 |
Incorporates large body of evidence | 156 | 19 |
Motivates patient to make lifestyle changes | 70 | 4 |
Promotes equity of treatment | 62 | 4 |
Scores QOF points | 21 | 1 |
Other | 4 | 1 |
Barriers | ||
Do not have time to use during a consultation | 163 | 24 |
Not relevant for use in all patients | 161 | 19 |
Not integrated with electronic patient records | 147 | 21 |
Do not know which risk score to use | 103 | 12 |
Do not include all risk factors | 92 | 9 |
Lack of link to clinical actions | 63 | 6 |
Do not add to my clinical judgement | 42 | 3 |
Encourage over-treatment | 34 | 4 |
Encourage under-treatment | 11 | 1 |
Other | 8 | 1 |
Undermine my professionalism | 4 | 1 |
Enablers | ||
Ensure good treatment decisions | 133 | 16 |
Integration with electronic patient records | 131 | 22 |
Quick to use | 126 | 17 |
Strong link to clinical action | 109 | 12 |
Add value to clinical judgement | 93 | 12 |
Provides justification for clinical decisions | 82 | 9 |
Easy to use | 80 | 9 |
Transparency of the methods behind the risk score | 32 | 2 |
Motivate patient to make lifestyle changes | 27 | 1 |
Well incentivised | 9 | 1 |
Other | 0 | 0 |